Ignite Creation Date:
2025-12-24 @ 5:49 PM
Ignite Modification Date:
2026-03-05 @ 5:41 AM
Study NCT ID:
NCT00317668
Status:
UNKNOWN
Last Update Posted:
2007-05-01
First Post:
2006-04-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Role of Antibodies Against Glutamate Receptors and Double Stranded DNA in Epilepsy Patients
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D004827', 'term': 'Epilepsy'}], 'ancestors': [{'id': 'D001927', 'term': 'Brain Diseases'}, {'id': 'D002493', 'term': 'Central Nervous System Diseases'}, {'id': 'D009422', 'term': 'Nervous System Diseases'}]}}, 'protocolSection': {'designModule': {'studyType': 'OBSERVATIONAL', 'designInfo': {'timePerspective': 'OTHER', 'observationalModel': 'DEFINED_POPULATION'}, 'enrollmentInfo': {'type': 'ESTIMATED', 'count': 250}}, 'statusModule': {'overallStatus': 'UNKNOWN', 'lastKnownStatus': 'RECRUITING', 'startDateStruct': {'date': '2006-11'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2006-04', 'lastUpdateSubmitDate': '2007-04-29', 'studyFirstSubmitDate': '2006-04-23', 'studyFirstSubmitQcDate': '2006-04-23', 'lastUpdatePostDateStruct': {'date': '2007-05-01', 'type': 'ESTIMATED'}, 'studyFirstPostDateStruct': {'date': '2006-04-25', 'type': 'ESTIMATED'}}, 'conditionsModule': {'conditions': ['Epilepsy']}, 'descriptionModule': {'briefSummary': 'The investigators will check the serum of epilepsy patients for antibodies against glutamate receptors and double stranded DNA. They will characterise the patients (by the kind of epilepsy, autoimmune disease comorbidity, and cognitive profile).'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'maximumAge': '90 Years', 'minimumAge': '18 Years', 'healthyVolunteers': True, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* 120 epilepsy patients from the epilepsy clinic and Emergency Room (ER)\n* Controls: 100 patients with other neurological diseases and no epilepsy; and 30 healthy volunteers.'}, 'identificationModule': {'nctId': 'NCT00317668', 'briefTitle': 'Role of Antibodies Against Glutamate Receptors and Double Stranded DNA in Epilepsy Patients', 'organization': {'class': 'OTHER', 'fullName': 'Hadassah Medical Organization'}, 'orgStudyIdInfo': {'id': 'autoimmunepi-HMO-CTIL'}}, 'contactsLocationsModule': {'locations': [{'city': 'Jerusalem', 'status': 'RECRUITING', 'country': 'Israel', 'contacts': [{'name': 'Dana Ekstein, MD', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Hadassah Ein-Kerem Medical Center', 'geoPoint': {'lat': 31.76904, 'lon': 35.21633}}], 'centralContacts': [{'name': 'Dana Ekstein, MD', 'role': 'CONTACT', 'email': 'dekstein@md.huji.ac.il'}], 'overallOfficials': [{'name': 'Dana Ekstein, MD', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'Hadassah Medical Organization'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Hadassah Medical Organization', 'class': 'OTHER'}}}}